Dirix, Piet <br/><br/>
Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Dec 2010 
 - 1373-80 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-355X 
<br/><br/><label>Standard No.: </label>10.1016/j.ijrobp.2009.10.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cisplatin--therapeutic use<br/>Combined Modality Therapy--adverse effects<br/>Dose Fractionation, Radiation<br/>Female<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Hypopharyngeal Neoplasms--drug therapy<br/>Laryngeal Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Mouth Neoplasms--drug therapy<br/>Neoplasm Staging<br/>Organs at Risk--diagnostic imaging<br/>Oropharyngeal Neoplasms--drug therapy<br/>Radiography<br/>Radiotherapy Planning, Computer-Assisted--methods<br/>Radiotherapy, Intensity-Modulated--adverse effects<br/>Retrospective Studies<br/>Survival Analysis<br/>Treatment Outcome<br/>Xerostomia--prevention & control